z-logo
open-access-imgOpen Access
MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
Author(s) -
Julius Strauss
Publication year - 2017
Publication title -
global journal of cancer therapy
Language(s) - English
Resource type - Journals
ISSN - 2581-5407
DOI - 10.17352/gjct.000019
Subject(s) - kras , colorectal cancer , cancer research , cancer , mutant , mek inhibitor , medicine , immune checkpoint , immunotherapy , biology , mapk/erk pathway , kinase , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom